Biodesix Inc (NAS:BDSX)
$ 1.295 -0.035 (-2.63%) Market Cap: 188.38 Mil Enterprise Value: 223.37 Mil PE Ratio: 0 PB Ratio: 6.82 GF Score: 67/100

Biodesix Inc at Cowen Health Care Conference Transcript

Mar 07, 2023 / 06:30PM GMT
Release Date Price: $1.78 (-1.11%)
Max Masucci
Cowen and Company - Analyst

(audio in progress) session here. Thanks again for being here, everybody. You've probably heard that, at least a few times, over the past day and a half, but we're pleased to be joined by Biodesix's CEO Scott Hutton. So number one, thanks for being here. And number two, why don't we jump in?

Scott Hutton
Biodesix, Inc. - CEO

Yeah, let's do it. Thanks, Max. It's great to be here. Great to be in person.

Max Masucci
Cowen and Company - Analyst

Yeah. Good to see each other in person. I do want to just give you an opportunity maybe to -- for those that are new to the story, just to give a brief overview and then you did just report. So a brief overview of the business and then how big is the business.

Scott Hutton
Biodesix, Inc. - CEO

Yeah. Yeah, Scott Hutton, Biodesix's CEO, as Max said. It's great to see you all. So we are a lung-based and lung-focused diagnostics company. We have five on-market tests, all with Medicare coverage,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot